RT Book, Section
A1 Friedman, Lawrence S.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193152448
T1 Nonalcoholic Fatty Liver Disease
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193152448
RD 2024/04/24
AB Key  Clinical  Updates  in  Nonalcoholic  Fatty  Liver  DiseaseNoninvasive  approaches  to  the  assessment  of  fibrosis  are  now  preferred,  with  liver  biopsy  reserved  when  results  of  noninvasive  testing  are  inconclusive.  The  FIB-4  score  is  often  used  particularly  to  exclude  advanced  fibrosis  because  of  its  simplicity.  It  is  based  on  age,  platelet  count,  and  serum  AST  and  ALT  levels.Younossi  ZM  et  al.  Am  J  Gastroenterol.  [PMID:  33284184]